US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Medicus Pharma Ltd.

3.33

-0.2550-7.12%

Volume:48.87K

Turnover:161.92K

Market Cap:4.20M

PE:-0.04

High:3.67

Open:3.54

Low:3.14

Close:3.58

52wk High:139.00

52wk Low:3.14

Shares:1.26M

Float Shares:1.01M

Volume Ratio:0.34

T/O Rate:4.83%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-82.9844

EPS(LYR):-136.7796

ROE:-7446.11%

ROA:-110.67%

PB:-2.38

PE(LYR):-0.02

Loading ...

Overview Company News Filings

Medicus Pharma Ltd trading halted, news pending

Medicus Pharma cites about $90M raised to advance CD228V, SkinJect, Teverelix

Medicus Pharma announces major share consolidation plan

Medicus Pharma - Announces Fifty-to-One Share Consolidation Effective October 12, 2026 - SEC Filing

THOMSON REUTERS

Medicus Pharma Effects 50-for-1 Share Consolidation Effective Oct. 12, 2026

Medicus Pharma Submits Teverelix Phase 2b/3 Registrational Protocol to FDA for Review

Medicus Pharma - Anticipates Gmp Manufacturing and Study Readiness Completion Before Year-End 2026

THOMSON REUTERS

Medicus Pharma Submits Optimized Teverelix® Registrational Protocol to FDA to Create Partner Ready Program in Advanced Prostate Cancer

THOMSON REUTERS

Medicus Pharma - Intends to Seek Strategic Partner or Out-License Teverelix Apc Program

THOMSON REUTERS

Medicus Pharma Narrows SkinJect Development to Gorlin Syndrome in Capital-Efficient Shift

Medicus Pharma Shifts SkinJect Development Focus to Gorlin Syndrome, Drops Sporadic Basal Cell Carcinoma Program

Medicus Pharma Announces Exclusive Development Focus for Skinject® in Gorlin Syndrome Following Commercial, Clinical and Regulatory Assessment

THOMSON REUTERS

Medicus Pharma - Terminates Standby Equity Purchase Agreement with Yorkville Effective Sept 11, 2026 - SEC Filing

THOMSON REUTERS

Medicus Pharma Announces Equity-Based Bonus Share Issuance

Analysts Offer Insights on Healthcare Companies: Medicus Pharma Ltd (MDCX) and Labcorp Holdings (LH)

Medicus Pharma Issues 8,529,412 Restricted Shares in Lieu of $1.45 Million Cash Bonuses

Medicus Selects 200 Μg SkinJect Patch as Lead Dose in Final Phase 2 Skin Cancer Study Report

Medicus Pharma Publishes Abridged Final Phase 2 Skinject® Clinical Study Report (CSR) Results Identifying 200 ΜG D-Mna Patch as the Lead Development Dose

THOMSON REUTERS

Analysts Are Bullish on These Healthcare Stocks: IDEAYA Biosciences (IDYA), Medicus Pharma Ltd (MDCX)

Medicus Pharma Sharpened Strategy Centers on Precision Oncology and Targeted Rare Disease Programs

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/stock/MDCX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MDCX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCX\",,,,,undefined,":{"symbol":"MDCX","market":"US","secType":"STK","nameCN":"Medicus Pharma Ltd.","latestPrice":3.325,"timestamp":1791917267897,"preClose":3.58,"halted":0,"volume":48865,"delay":0,"changeRate":-0.07122905027932958,"floatShares":1012050,"shares":1263600,"eps":-82.98445,"marketStatus":"Trading","change":-0.255,"latestTime":"10-13 14:47:50 EDT","open":3.54,"high":3.6748,"low":3.14,"amount":161923.061157,"amplitude":0.149385,"askPrice":3.55,"askSize":100,"bidPrice":3.15,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-82.98445,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791921600000},"marketStatusCode":2,"adr":0,"listingDate":1731560400000,"exchange":"NASDAQ","adjPreClose":3.58,"preHourTrading":{"tag":"盘前","latestPrice":3.55,"preClose":3.58,"latestTime":"09:29 EDT","volume":1802,"amount":6361.8427888,"timestamp":1791898199688,"change":-0.03,"changeRate":-0.00838,"amplitude":0.122905},"postHourTrading":{"tag":"盘后","latestPrice":3.82,"preClose":3.58,"latestTime":"19:57 EDT","volume":2688,"amount":10143.5544,"timestamp":1791849465093,"change":0.24,"changeRate":0.067039,"amplitude":0.072207},"volumeRatio":0.340616},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCX\",,,,,undefined,":{"symbol":"MDCX","floatShares":1012050,"roa":"-110.67%","roe":"-7446.11%","lyrEps":-136.77965,"volumeRatio":0.340616,"shares":1263600,"dividePrice":0,"high":3.6748,"amplitude":0.149385,"preClose":3.58,"low":3.14,"week52Low":3.14,"pbRate":"-2.38","week52High":139,"institutionHeld":0,"latestPrice":3.325,"eps":-82.98445,"divideRate":0,"volume":48865,"delay":0,"ttmEps":-82.98445,"open":3.54,"prevYearClose":76.5,"prevWeekClose":4.605,"prevMonthClose":8.05,"prevQuarterClose":8.05,"fiveDayClose":7.96,"twentyDayClose":7.605,"sixtyDayClose":17.7},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MDCX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-10-12","symbol":"MDCX","defaultRemindTime":1791811800000,"type":"split","dateTimestamp":1791777600000,"forFactor":50,"toFactor":1,"ratio":50},{"market":"US","date":"2026-08-12","symbol":"MDCX","fiscalQuarterEnding":"2026/06","expectedEps":-0.14,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-0.21},{"market":"US","date":"2026-05-14","symbol":"MDCX","fiscalQuarterEnding":"2026/03","expectedEps":-0.18,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"post","actualEps":-0.31},{"market":"US","date":"2026-03-25","symbol":"MDCX","fiscalQuarterEnding":"2025/12","expectedEps":-0.32,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774411200000,"reportTimeType":"post","actualEps":-0.82},{"date":"2025-11-14","symbol":"MDCX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1763154000000,"name":null,"time":"Post-Mkt","dateTimestamp":1763096400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MDCX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MDCX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1785470400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MDCX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MDCX","date":"2026-10-12","current":-0.040249,"percent":1,"low":-3.23298,"twenty":-2.078277,"median":-0.48947,"eighty":-0.299095,"high":-0.102694,"avg":-1.009724,"sd":0.942855,"marketCap":5818933},"quantilePoints":[{"date":"2025-08-29","current":-2.084531,"twenty":-2.272139,"median":-2.126221,"eighty":-2.109545,"marketCap":35632532},{"date":"2025-09-05","current":-1.907346,"twenty":-2.205434,"median":-2.115799,"eighty":-2.053263,"marketCap":32603766},{"date":"2025-09-12","current":-2.345097,"twenty":-2.211687,"median":-2.12101,"eighty":-2.053263,"marketCap":40086598},{"date":"2025-09-19","current":-2.532705,"twenty":-2.511859,"median":-2.178335,"eighty":-2.080362,"marketCap":43293526},{"date":"2025-09-26","current":-2.817408,"twenty":-2.759151,"median":-2.287772,"eighty":-2.103292,"marketCap":48160186},{"date":"2025-10-03","current":-3.005474,"twenty":-2.869667,"median":-2.511859,"eighty":-2.115799,"marketCap":51374941},{"date":"2025-10-10","current":-3.005474,"twenty":-2.994879,"median":-2.558762,"eighty":-2.122052,"marketCap":51374941},{"date":"2025-10-17","current":-2.885734,"twenty":-2.976858,"median":-2.720313,"eighty":-2.151236,"marketCap":49328130},{"date":"2025-10-24","current":-2.909682,"twenty":-2.974342,"median":-2.774974,"eighty":-2.174166,"marketCap":49737492},{"date":"2025-10-31","current":-2.957578,"twenty":-2.974342,"median":-2.817408,"eighty":-2.178335,"marketCap":50556216},{"date":"2025-11-07","current":-2.897708,"twenty":-2.962368,"median":-2.809662,"eighty":-2.228364,"marketCap":49532811},{"date":"2025-11-14","current":-2.706124,"twenty":-2.950394,"median":-2.817408,"eighty":-2.292984,"marketCap":46257915},{"date":"2025-11-21","current":-1.28141,"twenty":-2.950394,"median":-2.789942,"eighty":-2.178335,"marketCap":44939453},{"date":"2025-11-28","current":-1.355609,"twenty":-2.936025,"median":-2.763,"eighty":-2.119968,"marketCap":48464116},{"date":"2025-12-05","current":-1.183077,"twenty":-2.916866,"median":-2.742046,"eighty":-2.04284,"marketCap":42295956},{"date":"2025-12-12","current":-1.201563,"twenty":-2.904892,"median":-2.700137,"eighty":-1.376181,"marketCap":42956830},{"date":"2025-12-19","current":-1.022869,"twenty":-2.897708,"median":-2.63428,"eighty":-1.31987,"marketCap":36568379},{"date":"2025-12-26","current":-0.955088,"twenty":-2.897553,"median":-2.584818,"eighty":-1.266827,"marketCap":34145173},{"date":"2026-01-02","current":-1.074791,"twenty":-2.896932,"median":-2.511859,"eighty":-1.220048,"marketCap":38424640},{"date":"2026-01-09","current":-1.095865,"twenty":-2.885734,"median":-2.329463,"eighty":-1.179996,"marketCap":39178064},{"date":"2026-01-16","current":-0.976444,"twenty":-2.885734,"median":-2.178335,"eighty":-1.123965,"marketCap":34908660},{"date":"2026-01-23","current":-0.94132,"twenty":-2.866576,"median":-2.167912,"eighty":-1.101485,"marketCap":33652952},{"date":"2026-01-30","current":-0.878097,"twenty":-2.861786,"median":-2.115799,"eighty":-1.061072,"marketCap":31392680},{"date":"2026-02-06","current":-0.765701,"twenty":-2.861786,"median":-2.074108,"eighty":-1.022014,"marketCap":27374416},{"date":"2026-02-13","current":-0.709738,"twenty":-2.853549,"median":-1.933403,"eighty":-0.974021,"marketCap":25373688},{"date":"2026-02-20","current":-0.786136,"twenty":-2.850483,"median":-1.381324,"eighty":-0.961937,"marketCap":28104981},{"date":"2026-02-27","current":-0.97195,"twenty":-2.849812,"median":-1.344224,"eighty":-0.949581,"marketCap":34747976},{"date":"2026-03-06","current":-0.484474,"twenty":-2.849812,"median":-1.300152,"eighty":-0.949581,"marketCap":17320333},{"date":"2026-03-13","current":-0.412761,"twenty":-2.835443,"median":-1.263181,"eighty":-0.891018,"marketCap":14756541},{"date":"2026-03-20","current":-0.412761,"twenty":-2.825864,"median":-1.220048,"eighty":-0.847322,"marketCap":14756541},{"date":"2026-03-27","current":-0.387698,"twenty":-2.82079,"median":-1.201563,"eighty":-0.836077,"marketCap":18330934},{"date":"2026-04-02","current":-0.349652,"twenty":-2.811211,"median":-1.179996,"eighty":-0.820403,"marketCap":16532085},{"date":"2026-04-10","current":-0.367967,"twenty":-2.792337,"median":-1.125793,"eighty":-0.786136,"marketCap":17398052},{"date":"2026-04-17","current":-0.250001,"twenty":-2.775573,"median":-1.109135,"eighty":-0.744685,"marketCap":11820441},{"date":"2026-04-24","current":-0.276475,"twenty":-2.764797,"median":-1.099378,"eighty":-0.508201,"marketCap":13072156},{"date":"2026-05-01","current":-0.235266,"twenty":-2.75402,"median":-1.088841,"eighty":-0.417566,"marketCap":11123732},{"date":"2026-05-08","current":-0.277717,"twenty":-2.74923,"median":-1.069002,"eighty":-0.412761,"marketCap":13130880},{"date":"2026-05-15","current":-0.393186,"twenty":-2.733353,"median":-1.041354,"eighty":-0.401798,"marketCap":18590424},{"date":"2026-05-22","current":-0.308017,"twenty":-2.714637,"median":-1.024243,"eighty":-0.38811,"marketCap":15777036},{"date":"2026-05-29","current":-0.354651,"twenty":-2.703729,"median":-1.018593,"eighty":-0.376126,"marketCap":18165658},{"date":"2026-06-05","current":-0.402361,"twenty":-2.691755,"median":-0.976444,"eighty":-0.374724,"marketCap":20609444},{"date":"2026-06-12","current":-0.35842,"twenty":-2.672597,"median":-0.968141,"eighty":-0.372398,"marketCap":18358733},{"date":"2026-06-18","current":-0.378775,"twenty":-2.63428,"median":-0.962395,"eighty":-0.367967,"marketCap":19401342},{"date":"2026-06-26","current":-0.492235,"twenty":-2.63428,"median":-0.955088,"eighty":-0.371628,"marketCap":25212882},{"date":"2026-07-02","current":-0.442458,"twenty":-2.59471,"median":-0.94132,"eighty":-0.37203,"marketCap":22663265},{"date":"2026-07-10","current":-0.467347,"twenty":-2.543128,"median":-0.915037,"eighty":-0.3732,"marketCap":23938074},{"date":"2026-07-17","current":-0.449095,"twenty":-2.516028,"median":-0.871896,"eighty":-0.374395,"marketCap":23003214},{"date":"2026-07-24","current":-0.424981,"twenty":-2.511859,"median":-0.846653,"eighty":-0.374627,"marketCap":21768066},{"date":"2026-07-31","current":-0.290474,"twenty":-2.411802,"median":-0.843141,"eighty":-0.371929,"marketCap":14878433},{"date":"2026-08-07","current":-0.34025,"twenty":-2.326336,"median":-0.835949,"eighty":-0.363051,"marketCap":17428051},{"date":"2026-08-14","current":-0.353971,"twenty":-2.282561,"median":-0.821824,"eighty":-0.360424,"marketCap":20056990},{"date":"2026-08-21","current":-0.30351,"twenty":-2.211687,"median":-0.793282,"eighty":-0.354379,"marketCap":17197762},{"date":"2026-08-28","current":-0.298604,"twenty":-2.178335,"median":-0.778989,"eighty":-0.346389,"marketCap":16919767},{"date":"2026-09-04","current":-0.190112,"twenty":-2.172081,"median":-0.757549,"eighty":-0.339549,"marketCap":10772294},{"date":"2026-09-11","current":-0.179965,"twenty":-2.151236,"median":-0.709738,"eighty":-0.335,"marketCap":10197350},{"date":"2026-09-18","current":-0.190224,"twenty":-2.122052,"median":-0.541685,"eighty":-0.329543,"marketCap":10778612},{"date":"2026-09-25","current":-0.177066,"twenty":-2.115799,"median":-0.506615,"eighty":-0.313898,"marketCap":10033080},{"date":"2026-10-02","current":-0.175059,"twenty":-2.103292,"median":-0.499977,"eighty":-0.305853,"marketCap":9919355},{"date":"2026-10-09","current":-0.113621,"twenty":-2.080362,"median":-0.492235,"eighty":-0.299392,"marketCap":6438104},{"date":"2026-10-12","current":-0.102694,"twenty":-2.078277,"median":-0.48947,"eighty":-0.299095,"marketCap":5818933}],"updateTime":1791913894691},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MDCX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2674674668","title":"Medicus Pharma Ltd trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2674674668","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674674668?lang=en_us&edition=fundamental","pubTime":"2026-10-10 07:55","pubTimestamp":1791590114,"startTime":"0","endTime":"0","summary":"19:50 EDT Medicus Pharma (MDCX) Ltd trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving break...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/medicus-pharma-ltd-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/medicus-pharma-ltd-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673008691","title":"Medicus Pharma cites about $90M raised to advance CD228V, SkinJect, Teverelix","url":"https://stock-news.laohu8.com/highlight/detail?id=2673008691","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673008691?lang=en_us&edition=fundamental","pubTime":"2026-10-08 21:37","pubTimestamp":1791466650,"startTime":"0","endTime":"0","summary":"Medicus Pharma (MDCX) announced a shareholder update celebrating its third anniversary, saying approximately $90M raised through equity and debt fi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/medicus-pharma-cites-about-90m-raised-to-advance-cd228v-skinject-teverelix-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/medicus-pharma-cites-about-90m-raised-to-advance-cd228v-skinject-teverelix-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673651048","title":"Medicus Pharma announces major share consolidation plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2673651048","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673651048?lang=en_us&edition=fundamental","pubTime":"2026-10-08 04:31","pubTimestamp":1791405096,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd ( ($MDCX) ) has provided an update. Medicus Pharma Ltd. will implement a fifty‑to‑one consolidation of its common shares on Octo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-announces-major-share-consolidation-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-announces-major-share-consolidation-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673010481","title":"Medicus Pharma - Announces Fifty-to-One Share Consolidation Effective October 12, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2673010481","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673010481?lang=en_us&edition=fundamental","pubTime":"2026-10-08 04:07","pubTimestamp":1791403661,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nFWN45T102:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673432010","title":"Medicus Pharma Effects 50-for-1 Share Consolidation Effective Oct. 12, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2673432010","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673432010?lang=en_us&edition=fundamental","pubTime":"2026-10-08 04:07","pubTimestamp":1791403635,"startTime":"0","endTime":"0","summary":"Medicus Pharma effects 50-for-1 share consolidation effective Oct. 12, 2026Medicus Pharma will execute a 50-for-1 share consolidation effective Oct. 12, 2026.Nasdaq trading on a consolidated basis exp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nNDL4F3fhh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671534219","title":"Medicus Pharma Submits Teverelix Phase 2b/3 Registrational Protocol to FDA for Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2671534219","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671534219?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:32","pubTimestamp":1790681562,"startTime":"0","endTime":"0","summary":"Medicus Pharma submits Teverelix Phase 2b/3 registrational protocol to FDA for reviewMedicus submitted an optimized seamless Phase 2b/3 registration-intent protocol to the FDA for Teverelix in advance","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL6gGPCY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2210150020.SGD","LU2095319765.USD","MDCX","IE00BN0W2T93.GBP","NDAQ","SG9999014021.USD","BK4588","IE00BQXX3F31.USD","IE00BQXX3D17.EUR","SG9999014013.SGD","IE00B3QW5Z07.USD","LU0314104364.USD","IE00BN0W2W23.USD","LU2210149790.SGD","IE00BN0W2V16.EUR","BK4112","SG9999014005.SGD","IE00BGHQF748.EUR","BK4139","BCDF","IE00BKPKM429.USD","IE00BQXX3C00.GBP","SG9999014039.USD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671864219","title":"Medicus Pharma - Anticipates Gmp Manufacturing and Study Readiness Completion Before Year-End 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2671864219","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671864219?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:30","pubTimestamp":1790681402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA3HLMKT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671321986","title":"Medicus Pharma Submits Optimized Teverelix® Registrational Protocol to FDA to Create Partner Ready Program in Advanced Prostate Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2671321986","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671321986?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:30","pubTimestamp":1790681402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA3HLMKT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671219893","title":"Medicus Pharma - Intends to Seek Strategic Partner or Out-License Teverelix Apc Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2671219893","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671219893?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:30","pubTimestamp":1790681402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA3HLMKT:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MDCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669166116","title":"Medicus Pharma Narrows SkinJect Development to Gorlin Syndrome in Capital-Efficient Shift","url":"https://stock-news.laohu8.com/highlight/detail?id=2669166116","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669166116?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:15","pubTimestamp":1789996537,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd ( ($MDCX) ) has issued an update. Medicus Pharma has decided to restrict internally sponsored clinical development of its SkinJe...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-narrows-skinject-development-to-gorlin-syndrome-in-capital-efficient-shift?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-narrows-skinject-development-to-gorlin-syndrome-in-capital-efficient-shift?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MDCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669686791","title":"Medicus Pharma Shifts SkinJect Development Focus to Gorlin Syndrome, Drops Sporadic Basal Cell Carcinoma Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2669686791","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669686791?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:31","pubTimestamp":1789990301,"startTime":"0","endTime":"0","summary":"Medicus Pharma shifts SkinJect development focus to Gorlin syndrome, drops sporadic basal cell carcinoma programMedicus shifted SkinJect development to focus exclusively on Gorlin syndrome patients wi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDLb93hxX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3F31.USD","BK4588","NDAQ","SG9999014013.SGD","LU2210149790.SGD","IE00BN0W2T93.GBP","BCDF","SG9999014039.USD","IE00BQXX3D17.EUR","SG9999014005.SGD","BK4112","BK4585","LU2095319765.USD","IE00B64PRP62.GBP","SG9999014021.USD","LU2210150020.SGD","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","MDCX","LU0314104364.USD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4139","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669685168","title":"Medicus Pharma Announces Exclusive Development Focus for Skinject® in Gorlin Syndrome Following Commercial, Clinical and Regulatory Assessment","url":"https://stock-news.laohu8.com/highlight/detail?id=2669685168","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669685168?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:30","pubTimestamp":1789990201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nTUA7PJZFQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667656606","title":"Medicus Pharma - Terminates Standby Equity Purchase Agreement with Yorkville Effective Sept 11, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2667656606","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667656606?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:07","pubTimestamp":1789387623,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nFWN4530X4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666261522","title":"Medicus Pharma Announces Equity-Based Bonus Share Issuance","url":"https://stock-news.laohu8.com/highlight/detail?id=2666261522","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666261522?lang=en_us&edition=fundamental","pubTime":"2026-09-11 21:00","pubTimestamp":1789131603,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd ( ($MDCX) ) has issued an announcement. On September 4, 2026, Medicus Pharma Ltd. awarded approximately $1.45 million in cash bo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-announces-equity-based-bonus-share-issuance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-announces-equity-based-bonus-share-issuance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCX","BK4585","BK4215","BK4588","BK4139","REZ","EQR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666352286","title":"Analysts Offer Insights on Healthcare Companies: Medicus Pharma Ltd (MDCX) and Labcorp Holdings (LH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666352286","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666352286?lang=en_us&edition=fundamental","pubTime":"2026-09-11 20:30","pubTimestamp":1789129812,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Medicus Pharma Ltd (MDCX) and Labcorp Holdings (LH) ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-medicus-pharma-ltd-mdcx-and-labcorp-holdings-lh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-medicus-pharma-ltd-mdcx-and-labcorp-holdings-lh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","LU0006061336.USD","LU2237438978.USD","XBI","LABU","LU0251131958.USD","LU0029874061.USD","LH","BK4139","BK4550","XLV","MDCX","LU0742534661.SGD","LU0048573561.USD","BK4196","BK4581","BK4137","BK4585","LU1059921491.USD","BK4588","LU0128526141.USD","LU0251142724.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666521739","title":"Medicus Pharma Issues 8,529,412 Restricted Shares in Lieu of $1.45 Million Cash Bonuses","url":"https://stock-news.laohu8.com/highlight/detail?id=2666521739","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666521739?lang=en_us&edition=fundamental","pubTime":"2026-09-11 20:01","pubTimestamp":1789128118,"startTime":"0","endTime":"0","summary":"Medicus Pharma issues 8,529,412 restricted shares in lieu of $1.45 million cash bonusesMedicus Pharma issued 8,529,412 restricted common shares to officers and employees in lieu of about $1.45 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL6k8c9q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666359890","title":"Medicus Selects 200 Μg SkinJect Patch as Lead Dose in Final Phase 2 Skin Cancer Study Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2666359890","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666359890?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:52","pubTimestamp":1789041174,"startTime":"0","endTime":"0","summary":"Medicus selects 200 g SkinJect patch as lead dose in final Phase 2 skin cancer study reportMedicus posted an abridged final Phase 2 SkinJect Clinical Study Report for nodular basal cell carcinoma on S","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL37hzm2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4585","IE00BQXX3C00.GBP","IE00B64PRP62.GBP","IE00BKPKM429.USD","IE00BQXX3F31.USD","SG9999014013.SGD","LU0314104364.USD","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","IE00BQXX3D17.EUR","IE00BN0W2V16.EUR","LU2095319765.USD","SG9999014039.USD","BK4139","SG9999014021.USD","IE00BGHQF748.EUR","NDAQ","MDCX","BK4588","SG9999014005.SGD","BCDF","LU2210149790.SGD","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666988935","title":"Medicus Pharma Publishes Abridged Final Phase 2 Skinject® Clinical Study Report (CSR) Results Identifying 200 ΜG D-Mna Patch as the Lead Development Dose","url":"https://stock-news.laohu8.com/highlight/detail?id=2666988935","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666988935?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:30","pubTimestamp":1789039807,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nFWN4520UO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666536420","title":"Analysts Are Bullish on These Healthcare Stocks: IDEAYA Biosciences (IDYA), Medicus Pharma Ltd (MDCX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666536420","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666536420?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:40","pubTimestamp":1788961205,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on IDEAYA Biosciences (IDYA) and Medicus Pharma Ltd (MD...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-ideaya-biosciences-idya-medicus-pharma-ltd-mdcx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-ideaya-biosciences-idya-medicus-pharma-ltd-mdcx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4588","BK4585","XBI","BK4137","BK4581","XLV","MDCX","HCSG","LABU","IDYA","LU0029874061.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665730023","title":"Medicus Pharma Sharpened Strategy Centers on Precision Oncology and Targeted Rare Disease Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2665730023","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665730023?lang=en_us&edition=fundamental","pubTime":"2026-09-08 21:11","pubTimestamp":1788873063,"startTime":"0","endTime":"0","summary":"An announcement from Medicus Pharma Ltd ( ($MDCX) ) is now available. Medicus Pharma has repositioned itself as a precision oncology-led biotech, m...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-sharpened-strategy-centers-on-precision-oncology-and-targeted-rare-disease-programs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-sharpened-strategy-centers-on-precision-oncology-and-targeted-rare-disease-programs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","CNCR","BK4139","XBIX","MDCX","CANC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":96,"code":"91000000","status":"200"}]}}